Essbio S.A. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was CLP 56,545.71 million compared to CLP 49,745.3 million a year ago. Net income was CLP 5,792.08 million compared to net loss of CLP 2,917.9 million a year ago. Basic earnings per share from continuing operations was CLP 0.22 compared to basic loss per share from continuing operations of CLP 0.11 a year ago.
For the six months, sales was CLP 122,377.87 million compared to CLP 109,277.99 million a year ago. Net income was CLP 17,243.31 million compared to CLP 8,756.93 million a year ago. Basic earnings per share from continuing operations was CLP 0.65 compared to CLP 0.33 a year ago.